Improving the Odds: Recognizing and Managing Complicated Infections in the ICU CME

Marin Kollef, MD, FCCP; Lee Morrow, MD, FCCP; Lena M. Napolitano, MD, FCCP Author Information and Disclosures

Release Date: March 28, 2008; Valid for credit through March 28, 2009

Credits Available
Physicians - maximum of 2.0 AMA PRA Category 1 Credit(s)™ for physicians

Time of Completion: 120 Minutes

This CME program is based on a symposium that took place at the annual meeting of the American College of Chest Physicians, October 23-25, 2007 in Chicago, IL.

Participants will view this Web Cast and then participate in an online post-test and evaluation form: (1) review the target audience, learning objectives, and author disclosures; (2) study the educational content; (3) take the post-test and complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 American College of Chest Physicians and its Licensors.


Learning Objectives
Upon completion of this activity, participants should be able to:
  1. Discuss factors and impact on treatment decisions surrounding pneumonia in the ICU.
  2. Describe how protocols enhance the initial management of severe sepsis and septic shock.
  3. Review the advances that have been made in the management of complicated skin and soft-tissue infections.
Author Disclosures
Marin Kollef, MD, FCCP (Chair)
Disclosure: Dr. Kollef has received grant monies from and has been a consultant for C. R. Bard, Inc. He is on the speakers' bureau for Merck & Co., Inc., Pfizer Inc, Elan Corporation, plc, C. R. Bard, Inc., and Johnson & Johnson.

Lee Morrow, MD, FCCP
Disclosure: Dr. Morrow has no financial affiliations or relationships to disclose.

Lena M. Napolitano, MD, FCCP
Disclosure: Dr. Napolitano has participated on a speakers' bureau for Merck & Co., Inc., Pfizer Inc, and Wyeth. She has also been on an advisory committee for Merck & Co., Inc., Pfizer Inc, and Wyeth.
 
American College of CHEST Physcians
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the American College of Chest Physicians (ACCP).

The American College of Chest Physicians is accredited by the ACCME to provide continuing medical education for physicians.

The American College of Chest Physicians designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Anyone who attended "Improving the Odds: Recognizing and Managing Complicated Infections in the ICU" session at CHEST 2007 when this content was presented, and already claimed CME for this presentation, cannot claim CME from this enduring product. This product fulfills ACCP Learning Category II – Self Directed – Based Learning

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.